Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference
Rhea-AI Summary
Accolade (NASDAQ: ACCD) has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The event is scheduled for Thursday, September 5 at 9:15 am ET in New York. Investors and interested parties can access a live webcast of the presentation through Accolade's investor relations website at ir.accolade.com. For those unable to attend or watch live, a replay of the presentation will be available on the same platform for 90 days following the event. This conference provides Accolade with an opportunity to showcase its healthcare technology solutions to a global audience of investors and industry professionals.
Positive
- None.
Negative
- None.
SEATTLE, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5 at 9:15 am ET.
A webcast will be available at ir.accolade.com and a replay will be available for 90 days.
About Accolade, Inc.
Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over
Investor Contact:
Todd Friedman, Investor Relations, IR@accolade.com
Source: Accolade